NCT03186378View on ClinicalTrials.gov

Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions
Molluscum Contagiosum
Interventions
COMBINATION_PRODUCT

VP-102 with applicator

Subjects will receive treatment to their molluscum contagiosum with VP-102.

Trial Locations (1)

68522

Midwest Children's Health, Lincoln

Sponsors
All Listed Sponsors
collaborator

Paidion Research, Inc.

INDUSTRY

collaborator

Database Integrations, Inc.

INDUSTRY

collaborator

Cato Research

INDUSTRY

collaborator

Instat Services

INDUSTRY

lead

Verrica Pharmaceuticals Inc.

INDUSTRY

NCT03186378 - Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. | Biotech Hunter | Biotech Hunter